Antisense oligonucleotides directed to ribonucleotide reductase R2 and uses thereof in combination therapies for the treatment of cancer
A Standard patent application filed on 12 January 2005 credited to Young, Aiping H. ; Lee, Yoon ; Wright, Jim A.

Details

Application number :

2005203822  

Application type :

Standard  

Application status :

LAPSED  

Under opposition :

No  

Proceeding type :

 

Invention title :

Antisense oligonucleotides directed to ribonucleotide reductase R2 and uses thereof in combination therapies for the treatment of cancer  

Inventor :

Young, Aiping H. ; Lee, Yoon ; Wright, Jim A.  

Agent name :

Fisher Adams Kelly  

Address for service :

Level 29 12 Creek Street Brisbane QLD 4000 Australia  

Filing date :

12 January 2005  

Associated companies :

 

Applicant name :

Lorus Therapeutics Inc.  

Applicant address :

2 Meridian Road Toronto Ontario M9W 4Z7 Canada  

Old name :

Genesense Technologies Inc.  

Original Source :

Go